| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 23.307 | 34.164 | 89.506 | 95.831 | 141.342 | 197.045 | 78.732 | 87.579 | 121.469 | 37.443 |
| Total Income - EUR | 52.794 | 56.482 | 82.501 | 62.394 | 141.342 | 197.045 | 78.732 | 87.579 | 121.469 | 96.346 |
| Total Expenses - EUR | 51.945 | 56.138 | 81.095 | 55.087 | 62.774 | 69.186 | 60.129 | 60.735 | 73.286 | 81.753 |
| Gross Profit/Loss - EUR | 849 | 344 | 1.405 | 7.307 | 78.568 | 127.859 | 18.603 | 26.844 | 48.183 | 14.593 |
| Net Profit/Loss - EUR | 149 | 2 | 510 | 6.349 | 77.155 | 125.888 | 17.910 | 26.064 | 47.309 | 12.540 |
| Employees | 5 | 4 | 4 | 5 | 5 | 5 | 4 | 5 | 5 | 5 |
Check the financial reports for the company - Via Lab Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 17.769 | 8.358 | 1.167 | 7.549 | 4.515 | 1.597 | 0 | 0 | 0 | 0 |
| Current Assets | 44.741 | 66.145 | 83.606 | 82.466 | 157.161 | 271.529 | 281.813 | 285.747 | 336.913 | 341.839 |
| Inventories | 43.376 | 65.224 | 57.115 | 13.282 | 13.025 | 12.780 | 12.496 | 12.535 | 12.497 | 71.330 |
| Receivables | 1.276 | 747 | 26.429 | 61.656 | 135.145 | 256.591 | 225.985 | 269.479 | 323.303 | 269.041 |
| Cash | 89 | 174 | 62 | 7.529 | 8.991 | 2.158 | 43.331 | 3.733 | 1.113 | 1.468 |
| Shareholders Funds | 25.517 | 25.259 | 25.341 | 31.225 | 108.407 | 232.240 | 245.000 | 271.824 | 318.309 | 328.876 |
| Social Capital | 450 | 445 | 438 | 430 | 1.054 | 1.034 | 1.011 | 1.014 | 1.011 | 1.005 |
| Debts | 36.993 | 49.244 | 59.431 | 58.790 | 53.269 | 40.885 | 36.812 | 13.923 | 18.604 | 12.964 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7120 - 7120" | |||||||||
| CAEN Financial Year |
4120
|
|||||||||
Comments - Via Lab Srl